Preliminary Program - Friday, May 31

Print
Please click on the relevant day to view the applicable detailed program. To view the program overview, please click here

 

    Friday, May 31  
Wednesday, May 29 Thursday, May 30 Saturday, June 1
Friday, May 31, 2019
 
BREAKFAST IN FLORENCE
 
HALL A
07:30-8:30
NATIONAL SESSION | ITALY: Italian HAP Study Group
Chairpersons
 TBA
  Maternal hemodynamic in PET-IUGR
Daniel Di Martino

Maternal hemodynamics and placental Pathology in PE
Tiziana Frusca

Maternal hemodynamic and twin pregnancy
Tullio Ghi

Maternal hemodynamic and IUGR: Classification and treatment
Herbert Valensise

Hemodynamics and IUGR
Irene Giardina
In Parallel
HALL B
07:30-8:30
NATIONAL SESSION | CANADA
Chairpersons
 
   TBA
In Parallel
HALL C
07:30-8:30
NATIONAL SESSION | SERBIA
Chairpersons
 
   TBA
In Parallel
HALL D
07:30-8:30
NATIONAL SESSION | INDIA
Chairpersons
 
   TBA
In Parallel
HALL E
07:30-8:30
NATIONAL SESSION | BRAZIL
Chairpersons
 
   TBA
 
HALL A
08:30-09:00
BUON GIORNO FIRENZE – WAKING UP TO INNOVATIONS AND INVENTIONS
CAN RESEARCH ERRATUMS BE PREVENTED
Discussant
 Gian Carlo Di Renzo, Italy
 
THE QUESTION: Can Clinical Guidelines be protected from huge scientific erratum?
THE FACT: The TERM PROM trial as a model of recurrent scientific erratum
Eyal Krispin, Israel

Why was the sildenafil for fetal growth restriction (FGR) stopped - THE FACTS
Gerard Visser, The Netherlands
 
HALL A
09:00-10:30
SESSION 7A | MANAGEMENT OF HIP AND HAP
Chairpersons
 TBA
 
Risk engine approach to Hyperglycemia in Pregnancy
David McIntyre, Australia

Nutritional management of HIP
Ronald Ma, China
 
Metanalysis - Oral Hypoglycemic Agents management of HIP
Rosa Corcoy, Spain

Innovative pharma for prevention of PET
TBA

Glycated Albumin: a new tool for the metabolic monitoring in GDM
TBA

Metabolomics approach to screen patients with gestational diabetes
TBA
 

In Parallel
HALL B
09:00-10:30
SESSION 7B | PREVENTION OF GESTATIONAL HYPERGLYCEMIA
Chairpersons
 Gian Carlo di Renzo, Italy | Irene Cetin, Italy
 
Lifestyle
TBA
 
Exercise
Fionnuala McAuliffe, UK
 
Antioxidants
TBA
 
Inositols
TBA
 
Probiotics
Krisi Laitinen, Finland
In Parallel
HALL C
09:00-10:30
SESSION 7C | THE GAME CHANGERS: MEGA STUDIES: THE CONCEPTT STUDY
Chairpersons
 Rosa Corcoy, Spain | Helen Murphy, UK
 
What are the costs and benefits of Continuous Glucose Monitoring (CGM) in type 1 diabetes pregnancy?
 
A Canadian perspective from CONCEPTT
TBA
 
A UK perspective from CONCEPTT
TBA
 
CONCEPTT Metabolomics - New insights into maternal metabolism during type 1 diabetes pregnancy
Zoe Stewart, UK
 
Microparticles and novel molecular alterations associated with development of hypertensive disorders of pregnancy
TBA
 
Innovative mechanisms controlling glucose across the 24 hour day
Eleanor Scott, UK
In Parallel
HALL D
09:00-10:30
SESSION 7D | THE PLACENTA
Chairpersons
 Gernot Desoye, Austria
 
Placental gender AND SIZE
TBA
 
Placental autophagy in GDM
Anna Maria Marconi, Italy
 
GDM, maternal obesity and placental transcriptome
TBA
 
The metallome of the placenta in GDM
Enrico Cosmi, Italy
 
Obesity and first trimester placental development
Gernot Desoye, Italy

The evolving role of angiogenesis markers in managing high risk pregnancy
TBA
In Parallel
HALL E
09:00-10:30
SESSION 7E | MANAGEMENT OF HIGH RISK PREGNANCY - IT'S NOT ONLY ABOUT PREDICTION AND PREVENTION
Chairpersons
 Pantaleo Greco, Italy
  GDM in twin gestation - more good than harm?
TBA

Sleep and pregnancy complications
TBA

The maternal hemodynamic evaluation in managing preeclampsia
TBA

Preimplantation factor in pregnancy diagnostics and therapeutics
Michael Paidas, USA

Perinatal anesthesia in high risk pregnancy
TBA

Doppler and macrosomia
TBA
10:30-11:00
Coffee and Refreshment Break
 
HALL A
11:00-12:30
SESSION 8A | MATERNAL: PRETERM BIRTH
Chairpersons
 TBA

Managing PL and PROM: Roles for imaging and biomarkers
TBA


In Parallel
HALL B
11:00-12:30
SESSION 8B | INTERGENERATIONAL DIABETES AND OBESITY - CAN WE BREAK THE CYCLE?
Chairpersons
 TBA
 
Pre-conception strategies and interventions
TBA
 
Pregnancy interventions
Fionnuala McAuliffe, UK
 
Postnatal offspring and adult interventions
Ronald Ma, China
 
Bariatric surgery and Prevention of Pregnancy Complications
Eyal Sheiner, Israel
 
Obesity and diabetes: The maternal and children consequences
Elisabetta Torlone, Italy
In Parallel
HALL C
11:00-12:30
SESSION 8C | THE GAME CHANGERS: MEGA STUDIES: THE CONCEPTT STUDY
Chairpersons
 Denice Feig, Canada | Eleanor Scott, UK
 
Can Continuous Glucose Monitoring (CGM) measures replace HbA1c for assessment of maternal glucose control during type 1 diabetes pregnancy?
Rosa Corcoy, Spain
 
Can we predict which women do and don’t benefit from using Continuous Glucose Monitoring (CGM)
TBA
 
Clinical utility of novel and established markers of glucose control in women with type 1 diabetes in pregnancy
Claire Meek, UK
 
What level of intra-partum glucose control is safe for mothers and safe for babies
Jen Yamamoto, Canada
 
Which growth standards should be used to assess infant size in pregnancies affected by type 1 diabetes?
Claire Meek, UK
In Parallel
HALL D
11:00-12:30
SESSION 8D | NEW TRUFFLE STUDY
Chairpersons
 Enrico Ferrazzi, Italy

TBA


In Parallel
HALL E
11:00-12:30
SESSION 8E | EAPM
Chairpersons
 Diogo Ayres De Campos, Portugal
  Evidence-based intrapartum care
Diogo Ayres De Campos, Portugal

Perinatal decision making in ethical dilemmas of extreme prematurity
Daniel Surbek, Switzerland
Umberto Simeoni, Switzerland

Physical and sexual activity in pregnancy - is the sky the limit
TBA

Diabetes & Pregnancy, better control, bigger babies?
Gerard Visser, The Netherlands
 
HALL A
12:30-14:00
PLENARY SESSION 9 | THE GOLDEN FIRST TRIMESTER; PREDICTION AND PREVENTION OF PREGNANCY COMPLICATIONS
Chairpersons
 TBA
 
From common aneuploidy screening to screening for placental mediated complications
Liona Poon, Hong Kong
 
P&P of preterm birth
Eduardo Fonseca, Brazil
 
P&P of gestational diabetes
TBA
 
Genetic predisposition to preterm birth
Gian Carlo di Renzo, Italy
14:00-15:00
Lunch Break
 
HALL A
15:00-16:30
PLENARY SESSION 10 | INNOVATIVE INSULINS IN PREGNANCY
Chairpersons
 Moshe Hod, Israel | Graziano Di Cianni, Italy
 
Evaluating the safety of new pharma in pregnancy
Erica Nishimura, Denmark

Fetal growth velocity in GDM: correlation with metabolic control
Federico Mecacci, Italy
 
The Past; Critical evaluation of the insulin analogues in pregnancy studies
Annunziata Lapolla, Italy

The Future; The degludec in pregnancy study - the rational
TBA
 

 
HALL A
16:30-18:00
PLENARY SESSION 11 | INNOVATIVE MANAGEMENT OF HYPERTENSIVE DISORDERS IN PREGNANCY
Chairpersons
 TBA
 
Integrated approach for screening and prediction of preeclampsia in all three trimesters
TBA

Validation of the "traffic light" scheme of sFIt-1/PIGF for predicting preeclampsia in clinical practice
TBA

Enhanced prediction of preeclampsia by addition of NTproBNP to the sFIt-1/PIGF-Ratio
TBA

NK-Cell Memory and their role in the etiology of preeclamspia
TBA
 

 
HALL A
18:00-18:30
BUONA SERA FIRENZE – END OF DAY INNOVATIONS AND INVENTIONS
RESHAPING MATERNAL FETAL MEDICINE - INNOVATIVE NEW TECHNOLOGIES
Discussant
 Liona Poon, Hong Kong
 
The Proteome - Prediction of preterm birth
TBA